Cellyan Biotechnology Co., Ltd Restricted Cash And Cash Equivalents
Cellyan Biotechnology Co., Ltd (HKPD) had Restricted Cash And Cash Equivalents of $191.37 thousand as of 2025-09-30, per its 6-K filed 2026-03-18.
Financial Statements › Notes
ifrs-full:RestrictedCashAndCashEquivalents · last filed 2026-03-18
- 2025-09-30: Restricted Cash And Cash Equivalents $191.37K.
- 2025-03-31: Restricted Cash And Cash Equivalents $749.12K.
- 2024-09-30: Restricted Cash And Cash Equivalents $365.39K.
- 2024-03-31: Restricted Cash And Cash Equivalents $627.26K.
| Period end | Restricted Cash And Cash Equivalents |
|---|---|
| 2025-09-30 | $191.37K 6-K · filed 2026-03-18 |
| 2025-03-31 | $749.12K 6-K · filed 2026-03-18 |
| 2024-09-30 | $365.39K 6-K · filed 2026-03-18 |
| 2024-03-31 | $627.26K 6-K · filed 2026-03-18 |
| 2023-03-31 | $524.61K 20-F · filed 2025-08-14 |
| 2022-03-31 | $84.98K 20-F · filed 2025-08-14 |